Treatment and prevention of oral mucositis with growth factors
US5102870A · kind A · utility
38Cited by
4References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 14, 1989 |
| Grant date | Apr 7, 1992 |
| Priority date | — |
| Expiry date | Apr 14, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are provided of preventing and treating chemotherapy or radiotherapy induced oral mucositis in a mammal by administering an effective dose of a growth factor, such as TGF-.alpha.. The growth factor may be used alone or in combination with other growth factors. Typically the effective dose is within the range of about 0.01-100 .mu.g/dose, administered 2-4 times daily.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.